Clinical Trial Update: Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fecal microbiota transplantation before allogeneic stem cell transplant; recruitment is ongoing across multiple hematologic malignancie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Leukemia of Ambiguous Lineage
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Imperial College London | Conditions: Acute Lymphoblastic Leukaemia, Acute Leukemia of Ambiguous Lineage | Phase 2 | Status: RECRUITING